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Background: Perioperative hemodynamic fluctuations are seen more often in hypertensive patients than in
normotensive patients. The purpose of our study was to investigate the perioperative hemodynamic effects of
dexmedetomidine and midazolam used for premedication in hypertensive patients relative to each other and in
comparison to normotensive patients.
Methods: One-hundred-forty female, normotensive or hypertensive patients undergoing myomectomies or
hysterectomies. They were randomly enrolled into the subgroups: Group ND (normotensive-dexmedetomidine);
Group HD (hypertensive-dexmedetomine); Group NM (normotensive-midazolam); Group HM (hypertensive- midazolam).
Dexmedetomidine was administered at a concentration of 0.5 μg.kg−1, and midazolam was administered at a
concentration of 0.025 μg.kg−1 via intravenous (IV) infusion before the induction of anaesthesia. Haemodynamic
parameters were recorded at several times (Tbeginning, Tpreop5 min, Tpreop 10 min, Tinduction, Tintubation, Tintubation 5 min, Tinitial
surgery, Tsurgery 15 min, Tsurgery 30 min, Textubation, Textubation 5 min). Propofol amount for induction, time between induction and
initial surgery, demand of antihypertensive therapy, rescue atropine were recorded. Quantitative clinical and demographic
characteristics were compared using One Way ANOVA. The values were compared using One-way Analysis of Variance.
Additionally periodic variations were examined by One way Repeated Measures Analysis of Variance for groups separately.
Results: SBP was significantly different between normotensive and hypertensive groups at the following time points:
Tpreop 5 min, Tpreop 10 min, Tinduction, Tintubation, Tintubation 5 min and Tinitial surgery. MBP was significantly different in the
hypertensive groups at Tinduction, Tintubation, Tintubation 5 min, Tinitial surgery, Tsurgery 15 min, Tsurgery 30 min, Textubation and Textubation 5
min. The perioperative requirements for antihypertensive drugs were significantly higher in Group HM.
Conclusion: In the hypertensive patients, dexmedetomidine premedication provides better hemodynamic stability
compared with midazolam, and because it decreases the antihypertensive requirements, its use might be beneficial.
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Hypertension is the most common concomitant disease that
we encounter in the practice of anesthesia. In hypertensive
patients, excessive reduction in blood pressure is observed
after anesthetic induction, while excessive increases in
blood pressure are seen under stresses such as intubation,
laryngoscopy, surgical incision and extubation. A decrease
of greater than 20% in blood pressure can precipitates
myocardial ischemia; decreases in diastolic blood pressure
in particular can cause declines in both cerebral and
myocardial perfusion. Elevations in blood pressure may
cause myocardial ischemia and infarction by increasing
cardiac work. Perioperative and postoperative complications
in hypertensive patients are similar to those in normotensive
patients [1-5]. However, in a study that evaluated
17,638 patients who had shown side effects such as
hypotension and arrhythmias more frequently than
not experienced major complications such as death
and perioperative myocardial infarction in outpatient
hypertensive procedures [6].
In the American College of Cardiology and the American
Heart Association (ACC/AHA) guidelines for perioperative
cardiovascular assessment, the usage of α-2 agonists, such
as clonidine, is suggested in the treatment of perioperative
hypertension, particularly in the presence of coronary
disease. Furthermore, a limited number of studies have
evaluated the usage of dexmedetomidine [7,8]. Dexmede-
tomidine is 1600 times more selective to α-2 receptors
than to α-1 receptors (clonidine, 200:1), and this high
selectivity contributes to increases in hypnotic and
analgesic efficacies and decreases in cardiovascular side
effects [9,10]. Potentially desirable effects include decreased
requirements for other anesthetics and analgesics, a
diminished sympathetic response to stress and the potential
for cardioprotective effects against myocardial ischemia,
along with minimal effects on respiration [11]. Currently,
dexmedetomidine is being used in both the operating room
and diagnostic and procedure units in adult patients for
sedation and analgesic effects [12-16].
Some studies have compared dexmedetomidine versus
midazolam for sedation in critical patients in the inten-
sive care unit (ICU) setting [17]. However, we did not
find a study comparing the usage of dexmedetomidine
and midazolam for premedication in hypertensive
patients in the literature. In our previous study comparing
dexmedetomidine and midazolam for sedation during
endoscopy, we observed more hemodynamic stability
with dexmedetomidine, particularly in hypertensive
patients [18]. Because of this observation, we designed this
study with the hypothesis that the use of dexmedetomidine
would provide better hemodynamic stability and would
thus reduce the need for antihypertensive drugs in
hypertensive patients for premedication during anesthetic
management.Methods
Ethical approval for this study (Ethical Committee N°
2011/160) was provided by the Ethical Committee of
Duzce University, Duzce, Turkey. After written informed
consent from all patients was obtained, a total of 140
patients were included in our study between 10 January
2012 and 30 June 2013. The female patients included in
this study were 40–60 years of age, with a body mass
indices (BMIs) below 30 kg/m2, ASA I-II and were
scheduled to undergo myomectomies or hysterectomies.
Normotension was defined as a blood pressure below 140/
90 mm Hg. Hypertensive patients had stage 1 hypertension
(systolic blood pressure [SBP], 140–159 mmHg and
diastolic blood pressure [DBP], 90–99 mmHg) or
stage 2 hypertension (SBP; 160–179 mmHg and DBP;
100–109 mmHg) and were receiving antihypertensive
therapy. We excluded patients who were recently diagnosed
or were untreated; who were using angiotensin-converting
enzyme (ACE) inhibitors as antihypertensive treatment;
who had histories of myocardial infarction, heart block,
heart failure, renal, pulmonary, cerebrovascular diseases or
diabetes mellitus; who had difficult airways; whose
time between the induction and beginning of surgery
exceeded 15 min; and who required perioperative blood
transfusions. This study was registered with ClinicalTrials.
gov (NCT02058485).
Study design
The normotensive and hypertensive patients were
randomised into the 2 subgroups within themselves by a
computer program: Group ND, normotensive patients who
received dexmedetomidine; Group NM, normotensive
patients who received midazolam; Group HD, hypertensive
patients who received dexmedetomidine; Group HM,
hypertensive patients who received midazolam before
anesthesia. All patients were monitored by noninvasive
blood pressure, 5-lead electrocardiography, pulse oximetry
and bispectral index (BIS) using the same brand and model
monitor (Datex-Ohmeda S/5 compact anesthesia monitor,
GE Healthcare, Finland) that was being used in the
operating room. The study drugs were prepared in
40 ml with 0.9% NaCl that was infused intravenously
15 min before anesthetic induction. Group ND received
dexmedetomidine at a concentration of 0.5 μg.kg−1,
Group NM received midazolam at a concentration of
0.025 μg.kg−1, Group HD received dexmedetomidine at a
concentration of 0.5 μg.kg−1 and Group HM received
midazolam at a concentration of 0.025 μg.kg−1. These
drugs were calculated based on actual body weight and
were prepared by a blinded anesthesiologist. Researchers,
recorders and the attending anesthetist were blinded to
the groups, and the medications were computer-selected
from an unlabelled injector. For induction, 1 μg.kg−1 IV
fentanyl was administered, and propofol was administered
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was 60, at which point the propofol was stopped. The total
propofol amount for induction was recorded. Rocuronium
at a concentration of 0.6 μg.kg−1 IV was administered, and
endotracheal intubation was performed. Sevoflurane 1-2%
in mixed air and O2 (50:50) was used as maintenance and
was adjusted to maintain BIS values of 40–60. When the
blood pressure increased by more than 25% over two
consecutive measurements, nitro-glycerine infusion was
initiated as an antihypertensive. Atropine was given as a
0.5 mg IV bolus for bradycardia (heart rate 45 beat/min)
for at least 2 min. At the end of the surgery, sevoflurane
was stopped, and the patients were extubated when they
obeyed simple commands (eye opening, hand squeeze).
Data collection
Systolic blood pressure (SBP), diastolic blood pressure
(DBP), mean blood pressure (MBP) and heart rate (HR)
values were recorded at the beginning (Tbeginning), 5 min
after administration of the study drugs (Tpreop 5 min), 10 min
after administration of the study drugs (Tpreop 10 min),
immediately after induction of anesthesia (Tinduction),
1 min after intubation (Tintubation), 5 min after intubation
(Tintubation 5 min), at the initial time of surgery (Tinitial surgery),
15 min after the start of surgery (Tsurgery 15 min), 30 min
after the start of surgery (Tsurgery 30 min), 1 min after
extubation (Textubation) and 5 min after extubation
(Textubation 5 min). These values were primary outcomes
measures. The amount of propofol necessary for induc-
tion, the time between induction and initial surgery, the
requirement for antihypertensive therapy and the use of
rescue atropine were recorded as secondary outcomes mea-
sures. Bradycardia, dry mouth and respiratory depression
were evaluated as the side effects.
Statistical analysis
Based on similar conducted studies, a change in heart
rate by 10 beat/min had clinical significance in 4 groups
[19]. Additionally, the pooled variance from the groups
was determined to be approximately 12. Based on this
information, the required sample size was calculated to
be 30 for each group (total 120 patients) for a type I
error of 0.05 with a statistical power of 80%. The groups
were compared in terms of the patients’ clinical and
demographic features, and the data were analysed with
one-way variance analyses. To determine the categorical
features of patients and their relationship to the group
proper, x2 analyses (Likelihood Ratio or Pearson) were con-
ducted. Because the initial measurements of hemodynamic
parameters among the groups were significantly different,
an adjustment was made by emitting the initial values
from the values of the measurement period. After the
adjustment, new values of the groups were compared
by one-way variance analyses. Additionally, the separateperiodic changes in the 4 groups were analysed by one-
way repeated measures analysis of variance. A P < 0.05
was accepted as significant.
Results
A total of 140 patients were enrolled, but only data
from 119 patients were analysed in the study. (Group
ND, n = 29; Group HD, n = 30; Group NM, n = 30;
Group HM, n = 30) (Figure 1). There were no significant
differences in age, weight, duration of operation and
duration between induction and the start of surgery
among the groups (Table 1). A comparison of ASA phys-
ical status revealed a significant difference among the
groups (P = 0.006). The reason for this difference was that
all of the patients in the hypertensive groups (Groups HD
and HM) were assessed as ASA II, while some patients in
the normotensive groups (Groups ND and NM) were
assessed as ASA I.
The amount of propofol required for induction was
significantly different among the groups (P = 0.036). The
propofol requirements were highest in Group HM and
lowest in Group ND.
The perioperative requirement for antihypertensive
drugs was significantly higher in Group HM (P = 0.007)
(Table 1).
Regarding side effects, dry mouth was observed
most commonly in Group HD, followed by Group ND
(P < 0.001). The incidence of bradycardia was highest
in Group HD, followed by Group ND (P < 0.001). There
was no significant difference in atropine usage among
the groups (P = 0.530). Respiratory depression was not
observed (Table 2).
Comparison of hemodynamic data
There were significant differences in the initial values of
SBP, DBP and MBP (Tbeginning) among the groups.
These differences were due to the hypertensive and
normotensive groups. The hemodynamic comparisons
were performed after these initial differences were removed
statistically.
SBP was significantly different between the normotensive
and hypertensive groups at the following time points:
premedication 5th min (Tpreop 5 min, P < 0.001), premedica-
tion 10th min (Tpreop 10 min, P = 0.002), induction (Tinduction,
P < 0.001), intubation 1st min (Tintubation, P < 0.001),
intubation 5th min (Tintubation 5 min, P < 0.001) and
initial surgery (Tinitial surgery, P < 0.001). The mean
values of SBP at Tpreop 5 min, Tpreop 10 min and Tinduction
were significantly reduced in the hypertensive groups. In
particular, a marked reduction was noted in Group HM
after induction. The mean values of SBP at Tintubation,
Tintubation 5 min and Tinitial surgery were significantly increased
in the normotensive groups, particularly in Group NM.
There were significant differences at 15 min of surgery
Excluded ( n= 122)
• Not meeting inclusion criteria ( n= 105)
• Other reasons ( n= 17)
- Operation canceled ( n= 5)
- Staff were unavailable ( n=12)
Randomization ( n= 140)
Allocated to HD ( n= 35)
- Received allocated intervention ( n= 33)
- Did not receive allocated intervention ( n= 2)
• Protocol violation ( n= 2)
Allocated to HM ( n= 35)
-Received allocated intervention ( n= 35)
-Did not receive allocated intervention (n= 0)
Allocated to NM ( n= 35)
- Received allocated intervention ( n= 35)
- Did not receive allocated intervention ( n=0)
Allocated to ND ( n= 35)
- Received allocated intervention ( n= 34)
- Did not receive allocated intervention ( n= 1)












Discontinued intervention ( n= 3)
- Difficult intubation ( n= 1)
- Need for blood transfusion ( n= 2 )
Discontinued intervention ( n= 5)
- Difficult intubation ( n= 2)
- Need for blood transfusion ( n= 1 )
- Increased duration of surgery ( n=2 )
Discontinued intervention ( n= 5)
- Difficult intubation ( n= 5)
Discontinued intervention ( n= 5)
- Difficult intubation ( n= 2)
- Need for blood transfusion ( n= 2)












Assessed for eligibility ( n= 262)
Figure 1 CONSORT (Consolidated standards of reporting trials) flow diagram of the study.
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between the normotensive and hypertensive groups, but no
significance between the hypertensive groups. Nevertheless,
there were significant differences at 1 min after extubation
(Textubation) and 5 min after extubation (Textubation 5 min)
between Groups HD and HM. (Textubation, P = 0.018 and
Textubation 5 min, P < 0.001). Considering the averages, a
minimum increase was observed in Group HD (Figure 2).
DBP values did not differ significantly between the
groups at the different time points. However, the mean
value of DBP at Tpreop 5 min was significantly decreased
in Group HM (HM-ND P = 0.005; HM-NM P = 0.023;
HM-HD P = 0.029). In particular, a marked reduction
was noted after induction (Tinduction) in the hypertensive
groups (HD-ND P = 0.008; HD-NM P = 0.02; HM-NDTable 1 Demographic and clinical data of the study
ND (n = 29) HD
Age (yrs) 46 ± 5 4
Weight (kg) 72 ± 11 7
ASA (I/II) (n) 7/ 22
Stage of hypertension (1/2) (n) -
Duration of operation (min) 92 ± 25 8
Duration of induction-surgery (min) 17 ± 8 1
Propofol amount (mg) 86 ± 27 10
Rescue antihypertensive (%) 0
Values are displayed as means ± standard deviations, numbers, and percentages. *pP = 0.009; HM-NM P = 0.023). The values were significantly
higher in Group NM at Tinitial surgery, Tsurgery 15 min
and Tsurgery 30 min (Figure 2).
MBP significantly decreased in Group HM at Tpreop 5
min and Tpreop 10 min. In addition, MBP was significantly
lower in the hypertensive groups at the other time
points (Tinduction, Tintubation, Tintubation 5 min, Tinitial surgery,
Tsurgery 15 min, Tsurgery 30 min, Textubation and Textubation 5 min)
(Figure 2).
There was a significant difference in the initial values of
HR (Tbeginning) in Group ND (P = 0.009). The evaluation
was performed after this initial difference was removed sta-
tistically. HR significantly decreased in the dexmedetomi-
dine groups (Groups HD and ND), at the premedication
time points (Tpreop 5 min and Tpreop 10 min). When the mean(n = 30) NM (n = 30) HM (n = 30) p
9 ± 6 48 ± 6 46 ± 6 0.386
9 ± 10 74 ± 11 77 ± 11 0.087
0/30 5/25 0/30 0.002*
21/9 - 18/12 0.261
7 ± 26 81 ± 22 92 ± 22 0.248
4 ± 7 13 ± 4 14 ± 4 0.096
2 ± 34 95 ± 40 114 ± 44 0.036*
0 3 17 0.007*
< 0.05 compared between groups.
Table 2 Incidence of side effects
ND (n = 29) HD (n = 30) NM (n = 30) HM (n = 30) p
Dry mouth [n (%)] 7 (24)a,b 12 (40)b 2 (7)a 1 (3)a <0.001
*
Bradycardia [n (%)] 1 (38)a,b 18 (60)b 3 (10)a 4 (13)a <0.001
*
Respiratory depression [n (%)] 0 (0)a 0 (0)a 0 (0)a 0 (0)a 1
Rescue atropine [n (%)] 3 (10)a 4 (13)a 1 (3)a 2 (7)a 0.503
Values are displayed as percentages. *P < 0.05 compared between groups. In each row, same letters near the proportions were shown not statisticaly significant
differences between groups.
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Additionally, there were significant reductions in HR
at Tinduction, Tintubation, Tintubation 5 min, Tinitial surgery,
Tsurgery 15 min, Tsurgery 30 min, Textubation and Textubation 5 min
in Group HD (Figure 2).
Discussion
At the measured time points (after premedication,
induction of anesthesia intubation, early surgical
period and extubation) hypertensive patients showed
significant changes compared to normotensive patients.
There was no difference between dexmedetomidine and
midazolam use. However, the requirement for perioperative
antihypertensives was significantly higher in patients who
received midazolam. Because antihypertensives were used
in this group that interfered with blood pressure values, the
values were reduced to the blood pressure values of
patients that were treated with dexmedetomidine; therefore,Figure 2 Hemodynamic means of groups.it is possible that significant differences may have been
eliminated. If perioperative antihypertensive treatment
had not been administered in the hypertensive midazolam
patients, the data may have indicated a statistically signifi-
cant difference when compared to patients who were given
dexmedetomidine.
It is well known that perioperative hemodynamic fluctua-
tions are observed more often in hypertensive patients than
in normotensive patients [20]. These fluctuations can occur
for the duration of anesthesia and are well tolerated in
healthy individuals; however, these pressure changes and
increased sympathetic activity can have harmful effects on
hypertensive patients [21].
Ghignone et al. compared clonidine and diazepam as
premedications for normotensive and hypertensive
patients and found that clonidine was more effective in
preventing reflex tachycardia caused by laryngoscopy
and endotracheal intubation, and they reported that
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showed that oral clonidine as a premedication provided
more stable hemodynamics compared to placebo (in this
study, hypertension was not included in the study) [22].
Mariappan et al. showed similar hemodynamic profiles
when they compared oral clonidine premedication and
perioperative dexmedetomidine infusion [23]. Most
studies showed that, compared to saline, dexmedetomidine
as a premedication significantly decreased hypertensive
and tachycardia responses that occur due to intubation
[8,24-26]. Becker et al. reported that the dexmedetomidine
infusion after intubation in craniotomy patients resulted in
fewer antihypertensive requirements [27]. These studies
were conducted in normotensive patients. A study
comparing dexmedetomidine and three different doses
of midazolam showed that dexmedetomidine decreased
mean blood pressure and HR compared to all of the differ-
ent midazolam dosages [28]. Nevertheless, in all studies,
hypertensive patients were either excluded or mixed with
normotensive patients. In our study, it was established
that hemodynamic fluctuations were more common in
hypertensive patients than in normotensive patients.
Furthermore, we observed that the hemodynamic response
was more distinctive in hypertensive patients who received
midazolam as premedication, and the data indicated that
in the same group, the use of antihypertensive drugs was
more common.
Another parameter that we evaluated was the amount
of propofol used during induction in the different
groups. For this purpose, we used a propofol infusion
and BIS monitoring and stopped the infusion when BIS
reached 60. In the hypertensive groups, the propofol
requirement was higher, while in the dexmedetomidine
groups, a significant decrease in the requirement was
observed. Studies have shown that the perioperative and
preoperative usage of dexmedetomidine decreases the
requirement for anesthetics [24,25,29-32]. In these studies,
dexmedetomidine was compared only with saline. The re-
ducing effects of α-2 agonists on sympathetic neural activity
and catecholamine in circulation are responsible for the
decrease in anesthetic requirement [33]. In addition, it is
thought that α-2 agonists inhibit ion conduction through
types L and P Ca channels in the central nervous system
and stimulate K channels activated with voltage-related Ca.
Other sedatives have GABAergic effects that are different
from the hypnotic effects of dexmedetomidine.
In our study, the incidence of bradycardia was significantly
higher in the dexmedetomidine groups. This difference
was especially pronounced in the hypertensive patients.
However, the usage of rescue atropine was not significantly
different. Previous studies on the use of dexmedetomidine
in hypertensive patients did not specify heart rate charac-
teristics [10,34]. Nevertheless, in the study by Wallace et al.,
the frequency of bradycardia (<40 beats/min in the study)was reported to be 10% in the cardiovascular patients who
had been premedicated with clonidine [35]. In our study,
we accepted bradycardia at <45 beats/min; under this
condition, the bradycardia frequencies were 60% in
hypertensive patients and 38% in normotensive patients
who were treated with dexmedetomidine.
It is known that dexmedetomidine increases the fre-
quency of dry mouth due to the drug’s inhibitory effect on
salivation. In our study, dry mouth was also encountered
more commonly in patients who were treated with
dexmedetomidine, particularly Group HD.
During the planning of this study, we chose gynaecologic
operations to decrease hemodynamic changes caused by a
variety of surgical stimulations and gender. However, this
choice excluded the evaluation of hemodynamic changes in
male patients, which is one of the limitations of this study.
Conclusions
Based on our study, dexmedetomidine as a premedication
seems to be a better choice than midazolam for hyperten-
sive patients. In addition, dexmedetomidine may have the
benefit of decreasing anesthetic requirements. Nonetheless,
it should be taken into consideration that dexmedetomidine
increases the incidence of dry mouth and bradycardia in
hypertensive patients.
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